NewEdge Advisors’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.28M Buy
2,163
+428
+25% +$213K ﹤0.01% 1358
2025
Q4
$845K Buy
1,735
+650
+60% +$303K ﹤0.01% 1593
2025
Q3
$455K Sell
1,085
-172
-14% -$57.8K ﹤0.01% 1883
2025
Q2
$361K Buy
1,257
+403
+47% +$120K ﹤0.01% 1902
2025
Q1
$263K Sell
854
-2,173
-72% -$745K ﹤0.01% 1969
2024
Q4
$1.07M Buy
3,027
+1,679
+125% +$617K 0.01% 1122
2024
Q3
$483K Buy
1,348
+480
+55% +$162K ﹤0.01% 1503
2024
Q2
$277K Buy
868
+847
+4,033% +$224K ﹤0.01% 1763
2024
Q1
$4.82K Buy
21
+6
+40% +$1.35K ﹤0.01% 3150
2023
Q4
$3.3K Hold
15
﹤0.01% 3233
2023
Q3
$3.39K Sell
15
-7
-32% -$1.61K ﹤0.01% 2915
2023
Q2
$4.86K Sell
22
-942
-98% -$209K ﹤0.01% 2831
2023
Q1
$216K Sell
964
-1,261
-57% -$311K ﹤0.01% 1512
2022
Q4
$615K Sell
2,225
-171
-7% -$43.2K 0.02% 697
2022
Q3
$502K Buy
+2,396
New +$536K 0.01% 962
2022
Q1
Sell
-1,257
Closed -$272K 1629
2021
Q4
$272K Buy
+1,257
New +$247K ﹤0.01% 1370

Other funds holding UTHR